KRAS and non-small cell lung carcinoma: In this study, we developed a novel ferrocene complex, C16H20FeClNO, which inhibits the growth of K-Ras-driven human pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC) cells.